E Fund Management’s ResMed RMD Stock Holding History

E Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$419K	Buy	+1,867	New	+$465K	0.01%	322
2025 Q2	$369K	Sell	1,432 -287	-17%	-$68.5K	0.02%	270
2025 Q1	$385K	Buy	1,719 +47	+3%	+$11K	0.02%	255
2024 Q4	$382K	Buy	1,672 +718	+75%	+$173K	0.02%	264
2024 Q3	$233K	Buy	+954	New	+$213K	0.01%	295
2024 Q2	–	Sell	-1,177	Closed	-$233K	–	367
2024 Q1	$233K	Buy	+1,177	New	+$216K	0.01%	317
2022 Q1	–	Sell	-787	Closed	-$205K	–	352
2021 Q4	$205K	Buy	+787	New	+$204K	0.01%	258

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

E Fund Management's RMD Position: Q1 2026 in Review

E Fund Management opened a new position in ResMed (RMD) in Q1 2026: 1,867 shares worth $419K. The stake represents 0.01% of the portfolio and ranks #322 among its holdings. This is a return to the name: E Fund Management previously reported a position in RMD as recently as Q2 2025.

E Fund Management first reported a position in RMD in Q4 2021 and has held it in 7 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

E Fund Management held 1,867 shares of ResMed worth $419K as of Q1 2026.
ResMed was a new E Fund Management position in Q1 2026.
ResMed made up 0.01% of E Fund Management's portfolio in Q1 2026, its #322 holding.
E Fund Management first reported a position in ResMed in Q4 2021 and has held it in 7 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.